McIlrath & Eck’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-427
Closed -$40.4K 980
2024
Q1
$40.4K Buy
427
+276
+183% +$26.1K 0.01% 314
2023
Q4
$14K Sell
151
-269
-64% -$20.6K ﹤0.01% 491
2023
Q3
$26.9K Hold
420
0.01% 358
2023
Q2
$26K Hold
420
0.01% 373
2023
Q1
$24.4K Buy
420
+113
+37% +$6.5K 0.01% 375
2022
Q4
$18.3K Hold
307
﹤0.01% 422
2022
Q3
$19K Hold
307
0.01% 412
2022
Q2
$21K Hold
307
0.01% 379
2022
Q1
$22K Sell
307
-75
-20% -$5.04K 0.01% 381
2021
Q4
$26K Hold
382
0.01% 356
2021
Q3
$27K Buy
382
+148
+63% +$10.8K 0.01% 336
2021
Q2
$16K Buy
+234
New +$17K ﹤0.01% 434

Other funds holding NHC

McIlrath & Eck's NHC Position: Q2 2024 in Review

McIlrath & Eck sold out of National Healthcare (NHC) in Q2 2024, closing a stake of 427 shares — an estimated $40.4K sold.

McIlrath & Eck first reported a position in NHC in Q2 2021 and held it in 12 quarters. The position peaked at $40.4K in Q1 2024. 175 funds tracked by Wall St. Rank hold NHC as of Q2 2024.

  • McIlrath & Eck reported no remaining National Healthcare position as of Q2 2024 after selling out during the quarter.
  • McIlrath & Eck sold 427 National Healthcare shares in Q2 2024, an estimated $40.4K.
  • McIlrath & Eck first reported a position in National Healthcare in Q2 2021 and held it in 12 quarters.
  • McIlrath & Eck's National Healthcare position peaked at $40.4K in Q1 2024.
  • 175 funds tracked by Wall St. Rank held National Healthcare as of Q2 2024.

Based on McIlrath & Eck's 13F filing for Q2 2024, filed 14 Aug 2024.